These results imply that the immunosuppressive potential of cannabinoids could be very synergistic with immune checkpoint inhibitors since tumor cells use PD-1/PD-L1 signalling for their own survival (Bao et al., 2018). The gene discussed is PDCD1; the disease is neoplasm.